141 related articles for article (PubMed ID: 10168898)
1. Treatment of cytomegalovirus retinitis with the intraocular ganciclovir implant.
Anand R
Curr Opin Ophthalmol; 1997 Jun; 8(3):8-14. PubMed ID: 10168898
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant.
Muccioli C; Belfort R
Braz J Med Biol Res; 2000 Jul; 33(7):779-89. PubMed ID: 10881053
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of cytomegalovirus retinitis in AIDS with an intraocular sustained-release ganciclovir implant].
Mochizuki M; Ikeda E; Yoshimura K; Hikita N; Nagata Y; Iwamoto A; Fujino Y; Eguchi S; Oka S; Kimura S
Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):515-21. PubMed ID: 9754023
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
5. [Local therapy in treatment of cytomegalovirus (CMV) retinitis in AIDS. The ganciclovir implant (pellet)].
Fuchs AV; Schneider A; Schweykart N; Klauss V; Kampik A
Ophthalmologe; 1997 Oct; 94(10):719-23. PubMed ID: 9432240
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
Chang M; Dunn JP
Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
[TBL] [Abstract][Full Text] [Related]
7. [Pars plana implantation of a ganciclovir drug carrier in patients with cytomegalovirus retinitis and AIDS. Indications, follow-up and postoperative complications].
Gümbel H; Rosenkranz C; Schnaudigel OE; Mauck K; Fries U; Ohrloff C
Ophthalmologe; 1997 Oct; 94(10):713-8. PubMed ID: 9432239
[TBL] [Abstract][Full Text] [Related]
8. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
9. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of cytomegalovirus retinitis following the use of ganciclovir implants.
McCluskey PJ; Shah R; Versace P
Aust N Z J Ophthalmol; 1998 Aug; 26(3):207-10. PubMed ID: 9717750
[TBL] [Abstract][Full Text] [Related]
11. Ganciclovir implant exchange. Timing, surgical procedure, and complications.
Martin DF; Ferris FL; Parks DJ; Walton RC; Mellow SD; Gibbs D; Remaley NA; Ashton P; Davis MD; Chan CC; Nussenblatt RB
Arch Ophthalmol; 1997 Nov; 115(11):1389-94. PubMed ID: 9366668
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir.
Baudouin C; Chassain C; Caujolle C; Gastaud P
Ophthalmologica; 1996; 210(6):329-35. PubMed ID: 8887389
[TBL] [Abstract][Full Text] [Related]
13. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
14. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis.
Guembel HO; Krieglsteiner S; Rosenkranz C; Hattenbach LO; Koch FH; Ohrloff C
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):824-9. PubMed ID: 10502057
[TBL] [Abstract][Full Text] [Related]
15. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
16. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
Martin DF; Kuppermann BD; Wolitz RA; Palestine AG; Li H; Robinson CA
N Engl J Med; 1999 Apr; 340(14):1063-70. PubMed ID: 10194235
[TBL] [Abstract][Full Text] [Related]
17. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
18. Initial experience with an eight-month sustained-release intravitreal ganciclovir implant for the treatment of CMV retinitis associated with AIDS.
Duker JS; Robinson M; Anand R; Ashton P
Ophthalmic Surg Lasers; 1995; 26(5):442-8. PubMed ID: 8963859
[TBL] [Abstract][Full Text] [Related]
19. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options for resistant cytomegalovirus retinitis.
Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
